Drug-induced cardiac arrhythmias - Incidence, prevention and management

被引:23
作者
Doig, JC
机构
[1] Cardiology Department, North Tyneside General Hospital, North Shields, Rake Lane
[2] North Tyneside Health Care NHS Trust, North Tyneside General Hospital, N. Shields, Tyne and Wear NE29 8NH, Rake Lane
关键词
D O I
10.2165/00002018-199717040-00006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Drugs can cause cardiac arrhythmias in a number of clinical situations, and many of the implicated agents are used to treat non-cardiac conditions. These adverse effects are frequently idiosyncratic, but are often mediated via triggered activity causing torsade de pointes. Drugs being used for treatment of cardiac conditions may promote arrhythmias by re-entrant mechanisms or via triggered activity. Many drugs may cause cardiac arrhythmic complications when taken in excessive amounts. Keys to reducing the incidence of drug-induced cardiac arrhythmias include increased awareness among the medical, pharmaceutical and nursing professions of the potential problems in using certain agents, especially in specific situations. Appropriate monitoring when such treatment is essential and, after diagnosis, prompt withdrawal of the offending agent and treatment for the arrhythmia should be initiated.
引用
收藏
页码:265 / 275
页数:11
相关论文
共 89 条
[1]   CYCLE-LENGTH EFFECTS ON THE INITIATION OF SIMULATED TORSADE-DE-POINTES [J].
ABILDSKOV, JA ;
LUX, RL .
JOURNAL OF ELECTROCARDIOLOGY, 1994, 27 (01) :1-9
[2]   MECHANISMS IN SIMULATED TORSADE-DE-POINTES [J].
ABILDSKOV, JA ;
LUX, RL .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1993, 4 (05) :547-560
[3]   PHARMACODYNAMIC, PHARMACOKINETIC AND ANTIARRHYTHMIC PROPERTIES OF D-SOTALOL, THE DEXTRO-ISOMER OF SOTALOL [J].
ADVANI, SV ;
SINGH, BN .
DRUGS, 1995, 49 (05) :664-679
[4]   CISAPRIDE AND TORSADES-DE-POINTES [J].
AHMAD, SR ;
WOLFE, SM .
LANCET, 1995, 345 (8948) :508-508
[5]   INCREASED RISK OF DEATH AND CARDIAC-ARREST FROM ENCAINIDE AND FLECAINIDE IN PATIENTS AFTER NON-Q-WAVE ACUTE MYOCARDIAL-INFARCTION IN THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
AKIYAMA, T ;
PAWITAN, Y ;
GREENBERG, H ;
KUO, CS ;
REYNOLDSHAERTLE, RA .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (17) :1551-1555
[6]   FLUOROURACIL CARDIOTOXICITY [J].
ANAND, AJ .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (03) :374-378
[7]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[8]  
ARONSON JK, 1988, OXFORD TXB MED
[9]   Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart [J].
Asano, Y ;
Davidenko, JM ;
Baxter, WT ;
Gray, RA ;
Jalife, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (04) :831-842
[10]   ELECTROPHYSIOLOGIC PROFILE AND EFFICACY OF INTRAVENOUS DOFETILIDE (UK-68,798), A NEW CLASS-III ANTIARRHYTHMIC DRUG, IN PATIENTS WITH SUSTAINED MONOMORPHIC VENTRICULAR-TACHYCARDIA [J].
BASHIR, Y ;
THOMSEN, PEB ;
KINGMA, JH ;
MOLLER, M ;
WONG, C ;
COBBE, SM ;
JORDAENS, L ;
CAMPBELL, RWF ;
RASMUSSEN, HS ;
CAMM, AJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (14) :1040-1044